Drug Trial Radar · NCT05883241
Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Pain Related to Bone Fracture
Last checked: Nov 20, 2026Latest source record: Feb 28, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
90
Planned (sponsor's estimate)
Start
Jun 1, 2023
Primary completion
Feb 1, 2026
Study completion Feb 28, 2026
Sponsor
- Lead sponsor
- ZetrOZ, Inc.Industry
- Sponsor type
- Industry
- First posted
- May 31, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the ability of long-duration low-intensity therapeutic ultrasound (LITUS) to alleviate bone-fracture related pain over a 12-week period. The primary objective of this study is to evaluate the analgesic effect of LITUS in subjects suffering from bone-fracture pain. Secondary objectives are to assess the ability of LITUS to improve patients return to work time.
Conditions
- Bone Fracture
- Fresh Fracture
Interventions
Sustained Acoustic Device with 2.5% Diclofenac PatchDevice
Patients apply the SAM Ultrasonic Diathermy Device daily for 1-4 hours of continuous therapeutic ultrasound at 3-megahertz (MHz) frequency and 0.132 Watts/cm\^2 with 2.5% Diclofenac patches.
2.5% Diclofenac PatchesDrug
Topical pain relief-gel worn during treatment via SAM patch.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Pain Units on a Scale (0-10) 0 Being Least, 10 Being Worst Pain from BaselineTime frame: Through study completion, average of 12 weeks.
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
ZetrOZ Systems LLC
Trumbull, Connecticut · Recruiting
National Sports Medicine Institute
Lansdowne, Virginia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.